SARS-CoV-2 Archives -

Vaccine vial dose flu shot drug needle syringe,medical concept vaccination hypodermic injection treatment disease care hospital prevention immunization illness disease baby child.blue background

Pfizer, BioNTech submit to FDA for Covid vaccine in under 5s

Nicole Raleigh BioNTech, children's boosters, children's vaccines, coronavirus, covid, COVID-19, EUA, fda, Omicron, Pfizer, SARS-CoV-2 0 Comment

Pfizer and BioNTech have announced that they have submitted an Emergency Use Authorisation (EUA) to the US Food

Pfizer, BioNTech submit to FDA for Covid vaccine in under 5s

https://pharmaphorum.com/news/pfizer-biontech-submit-to-fda-for-covid-vaccine-in-under-5s/

R&D/ Views & Analysis/ Views and analysis

Overcoming the challenges of developing vaccines in an accelerated timeframe

mike.hammerton@pharmaphorum.com accelerated development, assays, covid19, immunogenicity, R&D, SARS-CoV-2, vaccines 0 Comment

The COVID-19 pandemic stopped the world in its tracks. It provided a range of new challenges for industry

Overcoming the challenges of developing vaccines in an accelerated timeframe

https://pharmaphorum.com/views-and-analysis/overcoming-the-challenges-of-developing-vaccines-in-an-accelerated-timeframe/

News/ News/ Pfizer/ Sales and Marketing

Pfizer plans considerable 2023 Comirnaty markup

Nicole Raleigh BioNTech, Comirnaty, commercialisation, COVID-19, Moderna, Pfizer, SARS-CoV-2, The People's Vaccine Alliance, vaccines 0 Comment

With US government supplies of Covid vaccines predicted to run out in the first quarter of 2023, it

Pfizer plans considerable 2023 Comirnaty markup

https://pharmaphorum.com/news/pfizer-plans-considerable-2023-comirnaty-markup/

News/ News/ Press Releases/ R&D

Vir awarded $1 billion multi-year BARDA influenza contract

Nicole Raleigh BARDA, COVID-19, GSK, influenza, pandemic, prevention, respiratory disease, SARS-CoV-2, sotrovimab, Vir Biotechnology, VIR-2482 0 Comment

The US Government’s Biomedical Advanced Research and Development Authority (BARDA) has made an initial investment of approximately $55

Vir awarded $1 billion multi-year BARDA influenza contract

https://pharmaphorum.com/news/vir-awarded-1-billion-multi-year-barda-influenza-contract/

News/ Pfizer/ Top pharmaceutical companies

Pfizer bivalent COVID-19 vaccine starts rollout

Nicole Raleigh bivalent vaccine, booster shot, COVID-19, flu season, NHS, Omicron, Pfizer, SARS-CoV-2 0 Comment

The NHS is moving to the next phase of its SARS-CoV-2 vaccination programme, following health secretary Steve Barclay’s

Pfizer bivalent COVID-19 vaccine starts rollout

https://pharmaphorum.com/news/pfizer-bivalent-covid-19-vaccine-starts-rollout-following-jcvi-approval/

ICMRA seeks international alignment on COVID-19 product assessment

R&D/ Views & Analysis/ Views and analysis

COVID-19 neutralising antibody tests – an integrated approach

Catherine Longworth antibody testing, COVID-19, immunology, SARS-CoV-2 0 Comment

Nina Garrett, R&D director at Abingdon Health discusses the key role antibody testing is playing in the pandemic

COVID-19 neutralising antibody tests – an integrated approach

https://pharmaphorum.com/views-and-analysis/covid-19-antibody-tests-integrated-approach/

Events/ Events/ Partner Content

Cell-Mediated Therapies for Infectious Disease Summit

jenna.warren@hansonwade.com immunogenic, infectious disease, SARS-CoV-2, T-cell, vaccine 0 Comment

Cell-Mediated Therapies for Infectious Disease Summit

https://pharmaphorum.com/events/cell-mediated-therapies-for-infectious-disease-summit/

Digital/ News/ News

UK groups get £12m funding for COVID-19 monitoring software

Phil Taylor COG-UK, coronavirus, COVID-19, genome sequencing, genomics, Sanger Institute, SARS-CoV-2, UK 0 Comment

Researchers at the Wellcome Sanger Institute in the UK are working on software to monitor the genome of

UK groups get £12m funding for COVID-19 monitoring software

https://pharmaphorum.com/news/uk-groups-get-12m-funding-for-covid-19-monitoring-software/

News/ News/ Sales and Marketing

UK doctors call for tighter rules on coronavirus antibody tests

Richard Staines coronavirus, SARS-CoV-2, testing 0 Comment

Doctors have called for rules to be tightened on coronavirus antibody tests in the UK amid fears that

UK doctors call for tighter rules on coronavirus antibody tests

https://pharmaphorum.com/news/doctors-call-for-tighter-rules-on-coronavirus-antibody-tests/

Trending

SARS-CoV-2

Login